Noninvasive measurement of blood glucose is a holy grail of medicine, with the potential to revolutionize diabetes management.
Integrity Applications,
an Israeli firm, has developed a device that looks like a pulse
oximeter that attaches to the ear lobe, but instead uses ultrasound,
electromagnetic, and thermal data to measure the amount of glucose
within the blood passing through the ear lobe. The firm already received
the CE Mark for their technology in Europe and a clinical trial in
preparation for FDA review is in the works.
Avner Gal, Co-Founder, President & CEO of Integrity Applications,
joined us to discuss the company’s technology, how it can impact
healthcare, and what the future holds for diabetes management and
treatment.
Here’s a recording of the hangout:
Post a Comment